 |
Nivolumab and Ipilimumab |
|---|---|
| Trade Name | |
| Orphan Indication | Stomach Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-12-20 00:00:00 |
| Sponsor | Bristol-Myers Squibb Co.;5 Research Parkway;Wallingford, Connecticut, 06492 |
Related Access Program
| |
Nivolumab and Ipilimumab |
|---|---|
| Trade Name | |
| Orphan Indication | Stomach Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-12-20 00:00:00 |
| Sponsor | Bristol-Myers Squibb Co.;5 Research Parkway;Wallingford, Connecticut, 06492 |